BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 31410983)

  • 1. Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation.
    Iba T; Levy JH; Warkentin TE; Thachil J; van der Poll T; Levi M;
    J Thromb Haemost; 2019 Nov; 17(11):1989-1994. PubMed ID: 31410983
    [No Abstract]   [Full Text] [Related]  

  • 2. Proposal of a two-step process for the diagnosis of sepsis-induced disseminated intravascular coagulation.
    Iba T; Levy JH; Yamakawa K; Thachil J; Warkentin TE; Levi M;
    J Thromb Haemost; 2019 Aug; 17(8):1265-1268. PubMed ID: 31099127
    [No Abstract]   [Full Text] [Related]  

  • 3. Sepsis and thrombosis.
    Levi M; Schultz M; van der Poll T
    Semin Thromb Hemost; 2013 Jul; 39(5):559-66. PubMed ID: 23625756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential diagnoses for sepsis-induced disseminated intravascular coagulation: communication from the SSC of the ISTH.
    Iba T; Levy JH; Wada H; Thachil J; Warkentin TE; Levi M;
    J Thromb Haemost; 2019 Feb; 17(2):415-419. PubMed ID: 30618150
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials.
    Umemura Y; Yamakawa K; Ogura H; Yuhara H; Fujimi S
    J Thromb Haemost; 2016 Mar; 14(3):518-30. PubMed ID: 26670422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboelastometry in patients with severe sepsis and disseminated intravascular coagulation.
    Sivula M; Pettilä V; Niemi TT; Varpula M; Kuitunen AH
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):419-26. PubMed ID: 19581801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human parechovirus sepsis induced coagulopathy in an infant.
    Bonnet JF; Connelly TM; Vega GH; Rodriguez Herrera A
    Enferm Infecc Microbiol Clin (Engl Ed); 2018 Feb; 36(2):143-144. PubMed ID: 28527677
    [No Abstract]   [Full Text] [Related]  

  • 8. Thromboelastometry as a supplementary tool for evaluation of hemostasis in severe sepsis and septic shock.
    Andersen MG; Hvas CL; Tønnesen E; Hvas AM
    Acta Anaesthesiol Scand; 2014 May; 58(5):525-33. PubMed ID: 24580049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difference between sepsis and trauma diagnosed as sensitive diagnostic criteria for disseminated intravascular coagulation.
    Wada H; Hatada T
    Thromb Haemost; 2008 Dec; 100(6):958-9. PubMed ID: 19132215
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of anticoagulant strategies on activation of inflammation and coagulation.
    Feistritzer C; Wiedermann CJ
    Expert Opin Biol Ther; 2007 Jun; 7(6):855-70. PubMed ID: 17555371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying Sepsis Populations Benefitting from Anticoagulant Therapy: A Prospective Cohort Study Incorporating a Restricted Cubic Spline Regression Model.
    Yamakawa K; Gando S; Ogura H; Umemura Y; Kabata D; Shintani A; Shiraishi A; Saitoh D; Fujishima S; Mayumi T; Kushimoto S; Abe T; Shiino Y; Nakada TA; Tarui T; Hifumi T; Otomo Y; Okamoto K; Kotani J; Sakamoto Y; Sasaki J; Shiraishi SI; Takuma K; Tsuruta R; Hagiwara A; Masuno T; Takeyama N; Yamashita N; Ikeda H; Ueyama M; Fujimi S;
    Thromb Haemost; 2019 Nov; 119(11):1740-1751. PubMed ID: 31408900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulopathy and platelet disorders in critically ill patients.
    Levi M; Schultz M
    Minerva Anestesiol; 2010 Oct; 76(10):851-9. PubMed ID: 20935621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progresses in characteristics and diagnostic methods of neonatal diffuse intravascular coagulation].
    Xu J; Pan XN
    Zhonghua Er Ke Za Zhi; 2013 Mar; 51(3):227-30. PubMed ID: 23751587
    [No Abstract]   [Full Text] [Related]  

  • 14. Low plasma FVII:C and activated FVII as predictive markers for overt disseminated intravascular coagulation.
    Lertthammakiat S; Anantasit N; Anurathapan U; Sirachainan N; Kadegasem P; Chuansumrit A
    Thromb Haemost; 2017 Jul; 117(8):1471-1477. PubMed ID: 28492702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The loss of homeostasis in hemostasis: new approaches in treating and understanding acute disseminated intravascular coagulation in critically ill patients.
    Hook KM; Abrams CS
    Clin Transl Sci; 2012 Feb; 5(1):85-92. PubMed ID: 22376264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and treatment of disseminated intravascular coagulation].
    Asakura H
    Rinsho Ketsueki; 2012 Oct; 53(10):1720-9. PubMed ID: 23037744
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathophysiology and diagnostic criteria for disseminated intravascular coagulation associated with sepsis.
    Wada H; Hatada T
    Crit Care Med; 2008 Jan; 36(1):348-9. PubMed ID: 18158452
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnosis and treatment of disseminated intravascular coagulation in COVID-19 patients: a scoping review.
    Mori H; Ohkawara H; Togawa R; Rikimaru M; Shibata Y; Ikezoe T
    Int J Hematol; 2021 Mar; 113(3):320-329. PubMed ID: 33550533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of cancer-associated disseminated intravascular coagulation: guidance from the SSC of the ISTH.
    Thachil J; Falanga A; Levi M; Liebman H; Di Nisio M;
    J Thromb Haemost; 2015 Apr; 13(4):671-5. PubMed ID: 25556711
    [No Abstract]   [Full Text] [Related]  

  • 20. Antithrombin as Therapeutic Intervention against Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation: Lessons Learned from COVID-19-Associated Coagulopathy.
    Wiedermann CJ
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.